Home/Filings/4/0001127602-25-003961
4//SEC Filing

Grogan Jane 4

Accession 0001127602-25-003961

CIK 0000875045other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 6:52 PM ET

Size

10.5 KB

Accession

0001127602-25-003961

Insider Transaction Report

Form 4
Period: 2025-02-06
Grogan Jane
Head of Research
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-07+1,3851,876 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-071,3852,770 total
    Exercise: $0.00Exp: 2027-02-07Common Stock (1,385 underlying)
  • Tax Payment

    Common Stock

    2025-02-07$141.35/sh443$62,6181,433 total
  • Award

    Restricted Stock Unit

    2025-02-06+5,6205,620 total
    Exercise: $0.00Exp: 2028-02-06Common Stock (5,620 underlying)
Footnotes (2)
  • [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.
  • [F2]The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Issuer

BIOGEN INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001995547

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:52 PM ET
Size
10.5 KB